News

The researchers also noted factors associated with people being less likely to receive optimal medical treatment for PAD, regardless of food access.

Researchers gathered the combined cardiovascular mortality data from the 2019 Global Burden of Disease study for both countries over the past 30 years, which totaled 33 million deaths.

The meta-analysis included results from the EMPA-KIDNEY Trial, the largest study to assess the use of SGLT-2 inhibitors in participants with chronic kidney disease.

The study included 117 adults with an average age of 65 years, and approximately 75% of the patients were male adults.

The participants were randomized to a low-dose statin medication rosuvastatin (5 mg daily), placebo, fish oil, cinnamon, garlic, turmeric, plant sterols or red yeast rice.

Principal Investigator: Roxana Mehran, MD, Director of Interventional Cardiovascular Research and Clinical Trials at the Icahn School of Medicine at Mount Sinai Conference: AHA Scientific Sessions – Featured Science...

For patients at risk for amputation because of severe peripheral artery disease (PAD) – who have a good single segment great saphenous vein and are deemed to be equal candidates for open surgery and endovascular revascularization – surgery...

The increases in death rates from heart disease in 2020 represented about five years of lost progress among adults nationwide and about 10 years of lost progress among younger adults and non-Hispanic Black adults.

Chest pain accounts for more than 6.5 million visits to U.S. emergency rooms each year. Yet little research has looked at what it might signify over the years to come, said the study's lead researcher, Dr. Kentaro Ejiri.

MOUNTAIN VIEW, Calif., Nov. 06, 2022 -- HeartFlow, Inc., announced new trial results that show evaluating patients with suspected CAD by applying advanced artificial intelligence (AI) to CCTA allows for more accurate non-invasive diagnosis,...